bf/NASDAQ:VRTX_icon.jpeg

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

492.26

26/07 20:00

Market Cap

126.86B

Beta: 0.49

Volume Today

773.74K

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
22.31M
-
22.50M
0.86%
43.47M
93.20%
66.84M
53.79%
94.72M
41.70%
118.09M
24.68%
145.93M
23.57%
224.14M
53.59%
316.94M
41.40%
406.85M
28.37%
599.70M
47.40%
average payables
75.31M
-
60.26M
19.98%
73.07M
21.25%
68.20M
6.67%
67.72M
0.70%
92.49M
36.57%
99.30M
7.36%
121.37M
22.23%
175.07M
44.24%
249.45M
42.49%
334.40M
34.05%
average receivables
114.38M
-
79.26M
30.71%
125.32M
58.12%
189.36M
51.11%
241.21M
27.38%
345.52M
43.24%
521.60M
50.96%
759.43M
45.60%
1.01B
33.14%
1.29B
27.54%
1.50B
16.54%
book value per share
6.03
-
4.66
22.76%
4.53
2.80%
5.47
20.78%
8.21
50.06%
17.44
112.53%
23.70
35.90%
33.43
41.04%
39.19
17.23%
54.33
38.61%
67.49
24.23%
capex per share
-0.23
-
-0.22
4.78%
-0.19
13.72%
-0.23
23.14%
-1.04
350.95%
-0.38
63.96%
-0.29
21.76%
-1.00
240.20%
-0.91
8.79%
-0.80
12.35%
-0.99
24.10%
capex to depreciation
-1.06
-
-0.81
23.83%
-0.73
10.22%
-0.92
26.78%
-4.23
358.65%
-1.32
68.78%
-0.71
46.51%
-2.37
236.23%
-1.87
21.13%
-1.38
26.23%
-1.43
3.26%
capex to operating cash flow
1.00
-
0.10
89.99%
0.12
24.26%
-0.24
293.25%
-0.31
28.16%
-0.08
75.51%
-0.05
36.06%
-0.08
66.09%
-0.09
11.33%
-0.05
44.24%
-0.07
47.38%
capex to revenue
-0.04
-
-0.09
108.03%
-0.04
50.25%
-0.03
24.28%
-0.10
213.70%
-0.03
69.93%
-0.02
42.17%
-0.04
130.98%
-0.03
25.89%
-0.02
26.12%
-0.03
14.58%
cash per share
6.51
-
5.89
9.51%
4.32
26.72%
5.86
35.72%
8.39
43.16%
12.46
48.45%
14.83
19.06%
25.63
72.76%
29.20
13.94%
42.09
44.13%
43.08
2.35%
days of inventory on hand
39.64
-
184.62
365.79%
163.06
11.68%
134.59
17.46%
148.36
10.24%
110.84
25.30%
111.62
0.70%
139.19
24.70%
142.54
2.41%
155.62
9.18%
213.64
37.28%
days payables outstanding
138.20
-
426.09
208.31%
217.89
48.86%
106.57
51.09%
98.17
7.89%
98.92
0.76%
58.38
40.98%
76.91
31.74%
78.72
2.35%
102.68
30.44%
105.52
2.77%
days sales outstanding
25.75
-
45.90
78.23%
62.81
36.83%
43.12
31.35%
41.26
4.30%
49.07
18.91%
55.55
13.21%
52.07
6.25%
54.78
5.20%
58.94
7.60%
58.00
1.60%
debt to assets
0.20
-
0.37
85.87%
0.36
0.94%
0.40
10.06%
0.17
58.66%
0.09
44.14%
0.07
20.92%
0.05
27.32%
0.04
15.36%
0.03
31.22%
0.04
15.07%
debt to equity
0.34
-
0.78
131.71%
0.83
6.21%
0.87
4.15%
0.29
66.81%
0.13
54.70%
0.10
23.24%
0.07
28.08%
0.06
16.79%
0.04
32.53%
0.05
14.04%
dividend yield
0.00
-
0.00
63.86%
0.00
2,314.00%
0.00
58.22%
earnings yield
-0.03
-
-0.03
0.79%
-0.02
30.43%
-0.01
66.18%
0.01
213.66%
0.05
604.33%
0.02
57.93%
0.04
110.91%
0.04
6.27%
0.04
8.53%
0.03
23.98%
enterprise value
16.58B
-
28.15B
69.79%
30.47B
8.22%
17.68B
41.98%
36.19B
104.71%
40.06B
10.67%
53.68B
34.01%
56.00B
4.33%
50.35B
10.09%
64.01B
27.13%
96.43B
50.64%
enterprise value over ebitda
32.86
-
-46.07
240.20%
-64.40
39.77%
1.15K
1,891.20%
116.21
89.93%
60.40
48.02%
36.82
39.04%
17.57
52.29%
18.06
2.78%
14.73
18.41%
24.53
66.49%
ev to operating cash flow
-321.55
-
-54.86
82.94%
-83.38
51.99%
74.88
189.81%
42.83
42.80%
31.53
26.38%
34.20
8.47%
17.21
49.68%
19.05
10.66%
15.50
18.63%
27.26
75.88%
ev to sales
13.68
-
48.51
254.54%
29.52
39.15%
10.39
64.81%
14.54
40.01%
13.14
9.62%
12.89
1.89%
9.02
30.01%
6.65
26.34%
7.17
7.82%
9.80
36.73%
free cash flow per share
-0.46
-
-2.40
423.93%
-1.70
29.04%
0.73
143.11%
2.35
220.65%
4.62
96.35%
5.82
25.96%
11.52
98.00%
9.35
18.88%
15.33
63.99%
12.59
17.88%
free cash flow yield
-0.01
-
-0.02
227.68%
-0.01
33.00%
0.01
173.63%
0.02
57.63%
0.03
77.57%
0.03
4.67%
0.05
83.43%
0.04
12.70%
0.05
24.71%
0.03
41.71%
graham net net
2.55
-
0.92
63.82%
-0.83
190.09%
0.28
133.71%
3.42
1,121.39%
6.79
98.40%
8.31
22.39%
16.93
103.64%
20.26
19.70%
30.66
51.32%
29.23
4.68%
graham number
16.39
-
18.14
10.69%
15.35
15.37%
7.51
51.10%
13.98
86.26%
56.89
306.84%
49.44
13.08%
88.60
79.19%
89.52
1.04%
125.92
40.65%
145.25
15.36%
income quality
0.08
-
0.69
821.20%
0.62
10.08%
-2.81
552.24%
9.22
428.17%
0.61
93.40%
1.33
119.10%
1.20
10.03%
1.13
5.93%
1.24
10.15%
0.98
21.39%
intangibles to total assets
0.01
-
0.03
120.72%
0.13
354.44%
0.12
13.71%
0.02
80.65%
0.01
63.97%
0.17
1,989.57%
0.12
29.22%
0.10
12.51%
0.09
10.72%
0.08
8.99%
interest coverage
-39.75
-
-9.50
76.09%
-5.57
41.43%
0.12
102.19%
2.14
1,655.09%
18.62
769.29%
20.47
9.96%
49.12
139.95%
45.24
7.90%
78.60
73.75%
85.04
8.19%
interest debt per share
2.14
-
3.95
85.00%
4.11
3.98%
5.06
23.21%
2.59
48.90%
2.40
7.14%
2.59
7.98%
2.62
1.16%
2.58
1.68%
2.40
6.83%
3.27
36.10%
inventory turnover
9.21
-
1.98
78.53%
2.24
13.23%
2.71
21.15%
2.46
9.29%
3.29
33.86%
3.27
0.70%
2.62
19.81%
2.56
2.35%
2.35
8.41%
1.71
27.16%
invested capital
0.34
-
0.78
131.71%
0.83
6.21%
0.87
4.15%
0.29
66.81%
0.13
54.70%
0.10
23.24%
0.07
28.08%
0.06
16.79%
0.04
32.53%
0.05
14.04%
market cap
16.71B
-
27.95B
67.29%
30.36B
8.62%
18.03B
40.63%
37.29B
106.89%
42.14B
12.99%
56.21B
33.39%
61.41B
9.25%
56.59B
7.85%
73.96B
30.69%
105.99B
43.32%
net current asset value
625.94M
-
308.01M
50.79%
-49.27M
116.00%
205.41M
516.90%
979.62M
376.90%
1.89B
93.09%
2.38B
25.61%
4.76B
100.33%
5.68B
19.38%
8.44B
48.59%
8.99B
6.53%
net debt to ebitda
-0.25
-
-0.33
28.68%
-0.22
31.66%
-22.55
9,982.09%
-3.54
84.32%
-3.14
11.19%
-1.74
44.71%
-1.70
2.35%
-2.24
31.90%
-2.29
2.30%
-2.43
6.31%
net income per share
-1.98
-
-3.14
58.62%
-2.31
26.31%
-0.46
80.20%
1.06
331.20%
8.25
678.83%
4.58
44.41%
10.44
127.66%
9.09
12.91%
12.97
42.72%
13.89
7.12%
operating cash flow per share
-0.23
-
-2.18
851.16%
-1.51
30.57%
0.96
163.72%
3.40
251.87%
5.00
47.13%
6.11
22.37%
12.52
104.83%
10.26
18.07%
16.13
57.20%
13.58
15.80%
payables turnover
2.64
-
0.86
67.57%
1.68
95.56%
3.42
104.45%
3.72
8.56%
3.69
0.76%
6.25
69.44%
4.75
24.09%
4.64
2.30%
3.55
23.34%
3.46
2.69%
receivables turnover
14.17
-
7.95
43.89%
5.81
26.91%
8.47
45.66%
8.85
4.50%
7.44
15.90%
6.57
11.67%
7.01
6.67%
6.66
4.94%
6.19
7.06%
6.29
1.63%
research and ddevelopement to revenue
0.76
-
1.47
94.43%
0.96
34.53%
0.62
36.22%
0.53
13.52%
0.46
12.68%
0.42
9.32%
0.29
30.05%
0.40
36.63%
0.28
29.39%
0.38
31.85%
return on tangible assets
-0.19
-
-0.33
67.47%
-0.26
20.76%
-0.04
83.04%
0.08
273.58%
0.34
345.30%
0.17
49.73%
0.26
53.98%
0.19
25.69%
0.20
3.67%
0.17
13.79%
revenue per share
5.39
-
2.47
54.23%
4.28
73.44%
6.96
62.61%
10.00
43.75%
11.98
19.84%
16.21
35.30%
23.88
47.29%
29.39
23.07%
34.87
18.64%
37.77
8.31%
roe
-0.33
-
-0.67
105.35%
-0.51
24.19%
-0.08
83.61%
0.13
254.07%
0.47
266.46%
0.19
59.10%
0.31
61.42%
0.23
25.71%
0.24
2.97%
0.21
13.77%
roic
-0.28
-
-0.28
0.28%
-0.20
30.47%
0.00
102.09%
-0.23
5,624.93%
0.40
275.56%
0.14
64.89%
0.25
80.77%
0.21
15.63%
0.23
6.74%
0.16
28.32%
sales general and administrative to revenue
shareholders equity per share
6.03
-
4.66
22.76%
4.53
2.80%
5.47
20.78%
8.21
50.06%
17.44
112.53%
23.70
35.90%
33.43
41.04%
39.19
17.23%
54.33
38.61%
67.49
24.23%
stock based compensation to revenue
0.11
-
0.31
191.22%
0.22
26.84%
0.14
37.60%
0.12
16.34%
0.11
8.70%
0.09
18.81%
0.07
20.08%
0.06
15.79%
0.06
5.60%
0.06
7.38%
tangible asset value
1.33B
-
1.03B
22.49%
757.96M
26.22%
1.00B
32.39%
1.96B
95.61%
4.38B
123.38%
4.68B
6.80%
7.28B
55.55%
8.70B
19.40%
12.22B
40.51%
15.65B
28.08%
tangible book value per share
5.42
-
4.37
19.49%
3.14
28.05%
4.10
30.57%
7.89
92.33%
17.24
118.61%
16.68
3.25%
26.50
58.81%
32.20
21.53%
47.72
48.20%
60.09
25.91%
working capital
1.19B
-
1.18B
0.91%
848.75M
28.07%
1.75B
106.55%
1.68B
4.39%
2.99B
78.20%
3.40B
13.99%
6.26B
84.00%
7.14B
13.99%
10.25B
43.54%
10.60B
3.38%

All numbers in USD (except ratios and percentages)